Press Releases & Announcements

STATEMENT ON THE CALIFORNIA WILDFIRES FROM ACTG LEADERSHIP AND DAIDS THERAPEUTICS RESEARCH PROGRAM LEADERSHIP

Jan 24, 2025

ACTG LAUNCHES SECOND HIV CURE CLINICAL TRIAL IN AFRICA

Jan 21, 2025

ACTG ANNOUNCES PUBLICATION OF BEE-HIVE TRIAL IN JAMA

Dec 04, 2024

ACTG PRESENTS TWO STUDIES PROVIDING INSIGHTS INTO TB TREATMENT AT UNION CONFERENCE ON LUNG HEALTH

ACTG, a global clinical trials network focused on HIV and other infectious diseases, announced two oral presentations on tuberculosis (TB)…

Nov 14, 2024

ACTG PRESENTS DATA ANALYSIS AT AIDS 2024 SHOWING ASSOCIATION BETWEEN ELEVATED RISK OF CARDIOVASCULAR EVENTS AND ABACAVIR USE AMONG PEOPLE LIVING WITH HIV

Jul 23, 2024

ACTG ANNOUNCES LAUNCH OF ITS FIRST HIV CURE CLINICAL TRIAL IN AFRICA

Jul 16, 2024

ACTG ANNOUNCES LAUNCH OF CLINICAL TRIAL EVALUATING DRUG-DRUG INTERACTION IN SHORTENED TUBERCULOSIS REGIMEN AMONG PEOPLE LIVING WITH HIV

PAUSE Study Is Evaluating two Long-Acting Broadly Neutralizing Antibodies

Jul 01, 2024

ACTG ANNOUNCES LAUNCH OF CLINICAL TRIAL EVALUATING COMBINATION OF THREE NOVEL IMMUNE-BASED THERAPIES FOR HIV CURE

Study will enroll participants who initiated treatment shortly after acquiring HIV

Apr 22, 2024

ACTG CROI 2024 PRESENTATIONS BY DATE AND TIME

Mar 08, 2024

ACTG CROI PRESENTATION DEMONSTRATES SUPERIORITY OF HEPB-CPG VACCINE OVER CONVENTIONAL HEPATITIS B VACCINE AMONG PEOPLE LIVING WITH HIV WHO HAVE NOT PREVIOUSLY RESPONDED TO VACCINATION

Mar 08, 2024

ACTG PRESENTS STUDY AT CROI DEMONSTRATING EFFICACY OF LONG-ACTING INJECTABLE TREATMENT AMONG PEOPLE WHO HAD PREVIOUSLY BEEN UNABLE TO MAINTAIN VIRAL SUPPRESSION ON DAILY ORAL MEDICATION

Mar 08, 2024

ACTG CROI PRESENTATIONS SHOW THAT SEMAGLUTIDE IMPROVES METABOLIC-ASSOCIATED STEATOTIC LIVER DISEASE AMONG PEOPLE LIVING WITH HIV

Mar 08, 2024